olsalazine has been researched along with Colitis Gravis in 92 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (44.57) | 18.7374 |
| 1990's | 33 (35.87) | 18.2507 |
| 2000's | 13 (14.13) | 29.6817 |
| 2010's | 2 (2.17) | 24.3611 |
| 2020's | 3 (3.26) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Li, Z; Liu, L; Ma, S; Mei, Q; Wang, J; Wang, S; Wang, X; Wang, Y; Xu, Z; Yan, R; Yang, P | 1 |
| Chen, J; He, B; Li, J; Li, S; Pu, Y | 1 |
| Tang, M; Xin, WF; Xu, YS; Yu, ZY | 1 |
| El-Kawy, OA; Farah, K; Ibrahim, IT | 1 |
| Luo, J; Wan, YM; Xia, B; Zhu, YQ | 1 |
| Schroeder, KW | 1 |
| Bjorkman, D; Kane, SV; Loftus, EV | 1 |
| Cui, HF; Jiang, XL | 1 |
| Archavlis, E; Christidou, A; Karagiannidis, A; Mantzaris, GJ; Petraki, K; Sfakianakis, M; Triadaphyllou, G | 1 |
| Baker, DE; Kane, S | 1 |
| Holland, S | 1 |
| Chang, EB; Hanauer, SB; Kles, KA; Musch, MW; Turner, JR; Vavricka, SR | 1 |
| Sandborn, WJ | 1 |
| Aymaz, S; Buschhausen, L; Krakamp, B; Kruis, W; Weber, M | 1 |
| Hanauer, SB; Huo, D; LoSavio, A; Rubin, DT; Yadron, N | 1 |
| Jewell, DP; Truelove, SC | 1 |
| Hansen, J; Lauritsen, K; Rask-Madsen, J; Ryde, M | 1 |
| Bukhave, K; Bytzer, P; Hansen, J; Lauritsen, K; Rask-Madsen, J | 1 |
| Järnerot, G; Ryde, M; Sandberg-Gertzén, H | 1 |
| Gabel, LP | 1 |
| Agback, H; Aronson, JK; Bodin, NO; Truelove, SC; Willoughby, CP | 1 |
| Garau, P; Kocoshis, SA; Neigut, DA; Orenstein, SR | 1 |
| Hentschel, E; Judmaier, G; Kayasseh, L; Kratochvil, P; Kruis, W; Scheurlen, C; Stolte, M; Theuer, D | 1 |
| Benno, P; Bergman, L; Danielsson, A; Fausa, O; Florholmen, J; Karvonen, AL; Kildebo, S; Kollberg, B; Löfberg, R; Nilsson, A | 1 |
| de Silva, HJ; Järnerot, G; Jewell, DP; Sandberg-Gertzén, H; Travis, SP; Tysk, C | 1 |
| Janowitz, HD; Kornbluth, AA; Mitty, R; Sacks, HS; Salomon, P | 1 |
| Ferry, GD; Fiedorek, SC; Grand, RJ; Griffiths, AM; Hassall, EG; Issenman, RM; Kirschner, BS; Vanderhoof, JA; Watkins, JB; Winter, HS | 1 |
| Gait, JE; Powell, JH; Regalli, G | 1 |
| Ferry, GD | 1 |
| Cuming, L; Jaskiewicz, K; O'Keefe, EA; Wright, JP | 1 |
| Becker, K; Ewe, K; Ueberschaer, B | 1 |
| Brignola, C; Campieri, M; Ferretti, M; Gionchetti, P; Miglioli, M; Rizzello, F; Venturi, A | 1 |
| Karamanolis, DG; Papatheodoridis, GV; Xourgias, V | 1 |
| Campbell, BJ; Dwarakanath, AD; Morris, AI; Rhodes, JM; Stevenson, A; Stretch, GL; Yaqoob, M | 1 |
| Gunnarsson, I; Lindblad, S; Pettersson, E; Ringertz, B | 1 |
| Amberiadis, P; Archavlis, E; Christoforidis, P; Florakis, N; Kourtessas, D; Mantzaris, GJ; Petraki, K; Spiliadi, C; Triantafyllou, G | 1 |
| Carlin, WV; Kumar, BN; Walsh, RM; Wilson, PS | 1 |
| Archimandritis, A; Hatzis, G; Konstandinidis, A; Paraskeva, K; Skandalis, N; Tzivras, M | 1 |
| Vuorinen, J | 1 |
| Steinberg, H | 1 |
| Brandes, JW; Ewe, K; Judmaier, G; Krakamp, B; Kruis, W; Lorenz-Mayer, H; Otto, P; Schreiber, S; Schütz, E; Theuer, D | 1 |
| Florholmen, J; Støa-Birketvedt, G | 1 |
| Berg, KJ; Birketvedt, GS; Fausa, O; Florholmen, J | 1 |
| Freyne, PJ; Kelleher, D; Mahmud, N; O'Hare, N; O'Toole, D; Weir, DG | 1 |
| Kiilerich, S; Ladefoged, K; Ranløv, PJ; Rannem, T | 1 |
| Rijk, MC; van Lier, HJ; van Tongeren, JH | 1 |
| Bergin, CF; Courtney, MG; Keeling, PW; Nunes, DP; O'Driscoll, M; Trimble, V; Weir, DG | 1 |
| Gait, JE; Simerl, NA | 1 |
| Maier, KP | 1 |
| Macrae, K; Record, CO | 1 |
| Allgayer, H; Kruis, W; Scheurlen, C; Scholz, R; Wedel, S; Zwiebel, FM | 1 |
| Gales, BJ; Segars, LW | 1 |
| Bukhave, K; Lauritsen, K; Rask-Madsen, J; Staerk Laursen, L; Stokholm, M | 1 |
| Das, KM; Molinas, S; Zinberg, J | 1 |
| Stern, WR | 1 |
| Cann, PA; Corbett, CL; Dundas, SA; Holdsworth, CD; Palmer, KR; Rao, SS | 1 |
| Lauritsen, K | 1 |
| Ireland, A; Jewell, DP | 3 |
| Barry, BA; Feurle, GE; Jantschek, G; Kruis, W; Sommer, A; Theuer, D; Velasco, S; Wördehoff, D | 1 |
| Bukhave, K; Lauritsen, K; Rask-Madsen, J; Staerk Laursen, L | 1 |
| Levinson, RA | 1 |
| Friedman, G | 1 |
| Järnerot, G; Kraaz, W; Sandberg-Gertzén, H | 1 |
| Cann, PA; Holdsworth, CD; Rao, SS | 1 |
| Breiling, J; Franke, M; Gabbert, H; Goerg, KJ; Meyer zum Büschenfelde, KH; Wanitschke, R | 1 |
| Sullivan, SN | 1 |
| Janowitz, HD; Meyers, S; Present, DH; Sachar, DB | 2 |
| Ireland, A; Jewell, DP; Mason, CH | 1 |
| Truelove, SC | 1 |
| Cowan, RE; Gould, SR; Machell, RJ; Stewart, JB; Willoughby, CP | 1 |
| Rijk, MC; van Schaik, A; van Tongeren, JH | 1 |
| Eckardt, V; Ewe, K; Kanzler, G | 1 |
| Järnerot, G | 1 |
| Barry, BA; Feurle, GE; Jantschegk, Y; Kruis, W; Sommer, A; Theuer, D; Velasco, S; Wördehoff, D | 1 |
| Bochner, F; Fitch, RJ; Gibson, GE; Hecker, R; Hetzel, DJ; Imhoff, DM; Labrooy, J; Rowland, R; Shearman, DJ | 1 |
| Berglindh, T; Campbell, DE | 1 |
| Bukhave, K; Lauritsen, K; Laursen, LS; Rask-Madsen, J | 1 |
| Agback, H; Ahnfelt, NO | 1 |
| Järnerot, G; Sandberg-Gertzén, H; Tysk, C | 1 |
| Inoue, M; Kondo, M; Munakata, A; Shiratori, T; Tsuchiya, S; Yoshida, Y | 1 |
| Meyers, S | 1 |
| Holdsworth, CD; Rao, SS; Read, NW | 1 |
| Dominick, HC; Ehringhaus, C | 1 |
| Barr, GD; Ireland, A; Jewell, DP; Mason, CH; Selby, WS | 1 |
| Hawkey, CJ | 1 |
12 review(s) available for olsalazine and Colitis Gravis
| Article | Year |
|---|---|
Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
Topics: Acute Disease; Administration, Oral; Administration, Rectal; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Enema; Humans; Mesalamine; Phenylhydrazines; Prodrugs; Sulfasalazine; Time Factors | 2002 |
Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Double-Blind Method; Humans; Mesalamine; Phenylhydrazines; Randomized Controlled Trials as Topic | 2004 |
The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Clinical Trials as Topic; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Labeling; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Product Surveillance, Postmarketing; Sensitivity and Specificity; Sulfasalazine | 2004 |
Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chemoprevention; Clinical Trials as Topic; Colitis, Ulcerative; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Mesalamine; Patient Compliance; Phenylhydrazines; Remission Induction; Sulfasalazine | 2006 |
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Mesalamine; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Remission Induction; Steroids; Sulfasalazine; Treatment Outcome | 1993 |
Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
Topics: Administration, Oral; Administration, Rectal; Aminosalicylic Acids; Chemistry, Pharmaceutical; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Interactions; Drugs, Investigational; Humans; Mesalamine | 1992 |
Olsalazine--a further choice in ulcerative colitis.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans | 1990 |
Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Inflammatory Bowel Diseases; Leukotriene B4; Mesalamine; Prostaglandins; Sulfasalazine; Thromboxane B2 | 1989 |
Sulfasalazine and new analogues.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
Evolution of olsalazine.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; History, 20th Century; Humans; Sulfasalazine; Sweden | 1988 |
Clinical tolerance of olsalazine.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Diarrhea; Humans; Mesalamine | 1988 |
Pharmacology of olsalazine.
Topics: Aminosalicylic Acids; Animals; Chemical Phenomena; Chemistry; Colitis, Ulcerative; Colon; Humans | 1988 |
42 trial(s) available for olsalazine and Colitis Gravis
| Article | Year |
|---|---|
Different therapy for different types of ulcerative colitis in China.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Antigens, CD; ATP Binding Cassette Transporter, Subfamily B, Member 1; China; Colitis, Ulcerative; Drugs, Chinese Herbal; Epithelial Cells; Female; Houttuynia; Humans; Male; Platelet Activation; Prednisolone; Sulfasalazine; Thrombosis; Thromboxane A2 | 2004 |
A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Analysis of Variance; Azathioprine; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Steroids; Treatment Outcome | 2004 |
[Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates].
Topics: Acute Disease; Adolescent; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Kidney Tubular Necrosis, Acute; Leukocyte Count; Male; Mesalamine; Middle Aged; Proteinuria; Risk Factors | 2006 |
Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Diarrhea; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Remission Induction; Safety; Sulfasalazine; Treatment Failure; Treatment Outcome | 1995 |
Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Diarrhea; Double-Blind Method; Female; Finland; Follow-Up Studies; Humans; Life Tables; Male; Norway; Recurrence; Sulfasalazine; Sweden; Time Factors; Treatment Outcome | 1995 |
Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Diarrhea; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Proctitis; Recurrence; Time Factors | 1994 |
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Mesalamine; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Remission Induction; Steroids; Sulfasalazine; Treatment Outcome | 1993 |
Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial.
Topics: Adolescent; Aminosalicylic Acids; Child; Child, Preschool; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Recurrence; Severity of Illness Index; Sulfasalazine | 1993 |
IBD: which 5-ASA drug works where?
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Recurrence | 1993 |
Olsalazine in maintenance of clinical remission in patients with ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Diarrhea; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Life Tables; Male; Recurrence; Time Factors | 1993 |
Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Colitis, Ulcerative; Convalescence; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intestinal Absorption; Male; Mesalamine; Metabolic Clearance Rate; Middle Aged; Polymethacrylic Acids | 1996 |
Systemic availability of 5-aminosalicylic acid: comparison of delayed release and an azo-bond preparation.
Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Colitis, Ulcerative; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Male; Mesalamine; Middle Aged; Prodrugs | 1996 |
Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Cross-Over Studies; Drug Administration Schedule; Female; Gastroscopy; Humans; Male; Mesalamine; Middle Aged; Treatment Outcome | 1996 |
5-amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine.
Topics: Absorption; Acetylation; Acetylglucosaminidase; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Sulfasalazine | 1996 |
A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Toxins; Betamethasone; Ciprofloxacin; Clostridioides difficile; Colectomy; Colitis, Ulcerative; Colonoscopy; Drug Combinations; Enema; Enterotoxins; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Placebos; Prednisolone; Prospective Studies; Remission Induction | 1997 |
Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine.
Topics: Administration, Oral; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Cross-Over Studies; Female; Humans; Male; Mesalamine; Middle Aged | 1997 |
Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Mesalamine; Middle Aged; Treatment Outcome | 1998 |
The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine.
Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Colon; Cross-Over Studies; Female; Humans; Male; Mesalamine; Middle Aged | 1999 |
Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis.
Topics: Adult; Albuminuria; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Mesalamine; Middle Aged | 2002 |
Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Humans; Middle Aged; Recurrence; Sulfasalazine | 1992 |
Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Sulfasalazine; Survival Analysis | 1992 |
Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Life Tables; Male; Mesalamine; Middle Aged; Patient Compliance; Recurrence; Remission Induction | 1992 |
Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Drug Carriers; Feces; Female; Humans; Male; Mesalamine; Middle Aged | 1990 |
Double-blind placebo-controlled study of olsalazine in the treatment of ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Patient Compliance; Remission Induction | 1990 |
Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Sulfasalazine | 1989 |
Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Randomized Controlled Trials as Topic | 1989 |
Sulfasalazine and new analogues.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Chemical Phenomena; Chemistry; Child; Colitis, Ulcerative; Diarrhea; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Middle Aged; Sulfasalazine | 1986 |
Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Middle Aged; Sulfapyridine; Sulfasalazine | 1987 |
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Prospective Studies; Random Allocation; Sulfasalazine | 1987 |
Olsalazine in patients intolerant of sulphasalazine.
Topics: Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Male; Middle Aged; Sulfasalazine | 1987 |
Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Rectum; Recurrence; Sigmoidoscopy; Sulfasalazine | 1988 |
Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
Topics: Administration, Oral; Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Prospective Studies; Random Allocation; Sulfasalazine | 1988 |
Evolution of olsalazine.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; History, 20th Century; Humans; Sulfasalazine; Sweden | 1988 |
Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation; Recurrence; Sulfasalazine; Time Factors | 1988 |
Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Random Allocation; Sulfasalazine | 1988 |
Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Proctitis; Random Allocation; Sulfasalazine | 1988 |
Clinical tolerance of olsalazine.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Diarrhea; Humans; Mesalamine | 1988 |
Olsalazine in the treatment of mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind, clinical trial.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Diarrhea; Double-Blind Method; Humans; Random Allocation | 1988 |
Olsalazine in the treatment of active ulcerative colitis: a placebo controlled clinical trial and assessment of drug disposition.
Topics: Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Proctitis; Random Allocation | 1988 |
Colonic prostaglandin E2 levels and olsalazine metabolism in relapsing ulcerative colitis: implications for controlled trials in the long term.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Colon; Dinoprostone; Female; Follow-Up Studies; Humans; Male; Mesalamine; Recurrence; Time Factors | 1988 |
Olsalazine in active ulcerative colitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Enema; Female; Humans; Male; Middle Aged; Random Allocation | 1985 |
42 other study(ies) available for olsalazine and Colitis Gravis
| Article | Year |
|---|---|
Pharmacokinetic and gut microbiota analyses revealed the effect of Lactobacillus acidophilus on the metabolism of Olsalazine in ulcerative colitis rats.
Topics: Aminosalicylic Acids; Animals; Colitis, Ulcerative; Gastrointestinal Microbiome; Lactobacillus acidophilus; Mesalamine; Probiotics; Rats | 2022 |
Orally Administrated Olsalazine-Loaded Multilayer Pectin/Chitosan/Alginate Composite Microspheres for Ulcerative Colitis Treatment.
Topics: Alginates; Chitosan; Colitis, Ulcerative; Humans; Microspheres; Pectins | 2023 |
The effect of olsalazine of chinese generic drugs on ulcerative colitis induced by dextran sulfate sodium salt in BALB/c mice.
Topics: Animals; China; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drugs, Generic; Epidermal Growth Factor; Interferon-gamma; Interleukin-10; Interleukin-17; Interleukin-2; Interleukin-7; Mice; Mice, Inbred BALB C; Tumor Necrosis Factor-alpha | 2023 |
Technetium-99 m labeling and evaluation of olsalazine: a novel agent for ulcerative colitis imaging.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Image Processing, Computer-Assisted; Isotope Labeling; Mice; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2015 |
Treating TNBS-induced colitis in rats with probiotics.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Therapy, Combination; Female; Interleukin-10; Peroxidase; Probiotics; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2011 |
[Oral therapy instead of enemas].
Topics: Administration, Oral; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Follow-Up Studies; Humans; Time Factors | 2003 |
When less is not more but at least equivalent.
Topics: Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents | 2004 |
Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Diarrhea; Disease Models, Animal; Gastrointestinal Agents; Ileum; Mesalamine; Phenylhydrazines; Prodrugs; Rabbits; Random Allocation; Sulfasalazine; Tissue Culture Techniques | 2005 |
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Case-Control Studies; Chemoprevention; Chronic Disease; Colitis, Ulcerative; Colorectal Neoplasms; Female; Humans; Logistic Models; Male; Middle Aged; Precancerous Conditions; Sulfasalazine | 2006 |
Disodium azodisalicylate in ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Male; Middle Aged | 1981 |
Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Colon; Feces; Female; Humans; Male; Middle Aged; Sulfasalazine | 1984 |
Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Colon; Dialysis; Dinoprostone; Feces; Female; Humans; Male; Middle Aged; Prostaglandins E; Sulfasalazine; Water | 1984 |
Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy.
Topics: Administration, Oral; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Ileostomy; Intestinal Absorption; Middle Aged | 1983 |
Sodium diazosalicylate.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans | 1982 |
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Administration Schedule; Feces; Half-Life; Humans; Kidney; Kinetics; Male; Middle Aged | 1982 |
Pancreatitis associated with olsalazine and sulfasalazine in children with ulcerative colitis.
Topics: Acute Disease; Adolescent; Aminosalicylic Acids; Amylases; Child; Colitis, Ulcerative; Female; Humans; Lipase; Male; Methylprednisolone; Pancreatitis; Sulfasalazine | 1994 |
Use of mesalamine and olsalazine in ulcerative colitis.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine | 1993 |
Olsalazine-induced lupus syndrome.
Topics: Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Lupus Erythematosus, Systemic | 1997 |
Sensorineural hearing loss and ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Autoimmune Diseases; Child; Colitis, Ulcerative; Drug Therapy, Combination; Hearing Loss, Sensorineural; Humans; Male; Prednisolone | 1997 |
A practical approach for the assessment of bioequivalence under selected higher-order cross-over designs.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Confidence Intervals; Cross-Over Studies; Humans; Models, Statistical; Reference Values; Therapeutic Equivalency | 1997 |
Efficacy of treatment for ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Mesalamine; Sulfasalazine | 1998 |
Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Gastrointestinal Agents; Humans; Kidney Diseases; Kidney Function Tests; Male; Mesalamine; Middle Aged; Retrospective Studies; Single-Blind Method; Sulfasalazine; Survivors | 2000 |
Comparisons of olsalazine and mesalazine in prevention of relapse in ulcerative colitis.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine; Recurrence; Research Design | 1992 |
[Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
Topics: Aminosalicylic Acids; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Sulfasalazine | 1992 |
Mesalazine versus olsalazine for prophylaxis of ulcerative colitis relapse.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Mesalamine; Recurrence | 1992 |
Olsalazine-related diarrhoea: does rat intestine adapt in vivo?
Topics: Adaptation, Physiological; Aminosalicylic Acids; Animals; Colitis, Ulcerative; Diarrhea; Intestinal Absorption; Intestinal Mucosa; Male; Rats; Rats, Inbred Strains | 1992 |
Olsalazine for ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Child; Clinical Trials as Topic; Colitis, Ulcerative; Humans | 1990 |
Food and Drug Administration's Gastrointestinal Drugs Advisory Committee. September 15-16, 1988. The ACG Committee on FDA-related matters. American College of Gastroenterology.
Topics: Alprostadil; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Evaluation; Humans; Misoprostol; Stomach Ulcer; United States; United States Food and Drug Administration | 1989 |
Sulfasalazine-induced impotence: a beneficial resolution with olsalazine?
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Erectile Dysfunction; Humans; Male; Middle Aged; Sulfasalazine | 1989 |
Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Dinoprostone; Feces; Female; Humans; Leukotriene B4; Male; Mesalamine; Middle Aged; Prostaglandins E; Rectum | 1988 |
Disodium azodisalicylate. American College of Gastroenterology Committee on FDA-Related Matters.
Topics: Aminosalicylic Acids; Chemical Phenomena; Chemistry; Colitis, Ulcerative; Humans; Sulfasalazine | 1985 |
Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon i
Topics: Aminosalicylic Acids; Animals; Colitis, Ulcerative; Colon; Ileum; Intestinal Absorption; Intestinal Mucosa; Mesalamine; Rats; Rats, Inbred Strains; Sulfapyridine; Sulfasalazine | 1987 |
Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate.
Topics: Adult; Aminosalicylic Acids; Bronchiolitis Obliterans; Colitis, Ulcerative; Desensitization, Immunologic; Humans; Male; Mesalamine; Pulmonary Eosinophilia; Pulmonary Fibrosis; Sulfasalazine | 1987 |
Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Female; Humans; Male; Mesalamine; Sulfasalazine | 1988 |
Proceedings of the First International Symposium on Olsalazine in the Treatment of Ulcerative Colitis. Oxford, March 1987.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans | 1988 |
Olsalazine-O-sulphate: an acid labile metabolite of olsalazine.
Topics: Aminosalicylic Acids; Chromatography, Liquid; Colitis, Ulcerative; Humans | 1988 |
Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention: a follow-up study.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Follow-Up Studies; Humans; Recurrence; Retrospective Studies; Time Factors | 1988 |
Olsalazine in active ulcerative colitis: dose finding study in Japan.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Japan; Random Allocation | 1988 |
Olsalazine and GI transit in UC.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Diarrhea; Gastrointestinal Transit; Humans | 1988 |
Influence of olsalazine on gastrointestinal transit in ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Defecation; Diarrhea; Feces; Female; Gastric Emptying; Gastrointestinal Transit; Humans; Male; Middle Aged | 1987 |
[Gastrointestinal incompatibility of azodisalicylate].
Topics: Aminosalicylic Acids; Child; Colitis, Ulcerative; Female; Humans; Nausea | 1986 |
Salicylates for the sulfa-sensitive patient with ulcerative colitis?
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans | 1986 |